<DOC>
	<DOCNO>NCT00404287</DOCNO>
	<brief_summary>Atherosclerosis aortic stenosis share inflammatory etiopathogenic characteristic common . We hypothesize statin therapy would decrease inflammatory marker concentration patient degenerative aortic stenosis halt haemodynamic progression disease .</brief_summary>
	<brief_title>Randomized Study Evaluate Efficacy Fluvastatin Inflammatory Markers Patients With Aortic Stenosis .</brief_title>
	<detailed_description>This study prospective , phase IV-III , randomize , double blind , active control study , evaluate efficacy fluvastatin inflammatory marker haemodynamic progression degenerative aortic stenosis . We hypothesize statin therapy would decrease inflammatory marker concentration patient degenerative aortic stenosis halt haemodynamic progression disease . Eligible patient degenerative aortic stenosis randomize 1:1 fluvastatin 80 mg daily placebo . The treatment continue study end ( 12 month ) . Follow investigation perform 3 month end study ( 12 month ) .</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<mesh_term>Fluvastatin</mesh_term>
	<criteria>1 . Age ≥ 18 year 2 . Asymptomatic 3 . Aortic stenosis define aortic valve leaflet thicken reduce systolic opening ( maximum aortic jet velocity &gt; 2 m/s ) 4 . Written inform consent participate study 5 . Patients capable follow condition along study . 1 . Symptomatic patient cause aortic stenosis . 2 . Patients statin anytime year inclusion . 3 . Patients diagnose dyslipidemia requiring statin . 4 . Temperature ³37,8 ºC week inclusion . 5 . Any cardiovascular event succeed three month inclusion 6 . Known thyrotoxicosis 7 . Renal failure require hemodialysis 8 . Any inflammatory noncardiac disease reason know influence study biomarkers concentration . 9 . Any surgery succeed three month inclusion . 10 . Patients hepatopathy view investigator prohibit participation study . 11 . Patients know muscular disease . 12 . Patients severe medical condition view investigator prohibit participation study 13 . Use corticoid , immunosuppressor non steroid drug . 14 . Any known sensitivity study drug ( fluvastatin ) class study drug . 15 . Patients participate study last year . 16 . Women childbearing potential use contraception method ( ) specify study , suspicion pregnancy , well woman breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>C reactive protein</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Aortic valve stenosis</keyword>
	<keyword>progression</keyword>
</DOC>